Although it was first reported by Vogelstein et al. as a WHO-grade 4 glioblastoma; recent analyses have shown that most WHO grade 2 and 3 astrocytoma/oligodendrogliomas are characterized by IDH1/2 mutations [35]. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).